Details of the Drug

General Information of Drug (ID: DMVW5LN)

• Drug Name: ACER-002

Indication

Disease Entry	ICD 11	Status	REF
Ehlers-Danlos syndrome	LD28.1	Phase 3	[1]

• Cross-matching ID:
  PubChem CID: 42373
  TTD ID: D0X9KB

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)